Phase 3 Readout~month
Phase 3 Topline: Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donor
- Company
- HWH International Inc. (HWH)
- Drug
- unrelated
- Indication
- Healthy
Other upcoming events for HWH
Phase 2 StartPhase 2 Start: Phase 2 Randomized Controlled Study of Revumenib as Maintenance Therapy After Allogeneic Hematopoiet
Phase 3 ReadoutPhase 3 Topline: An Open Label, Randomized Non-Inferiority Trial Comparing Safety and Immunogenicity of Intradermal V
Phase 3 ReadoutPhase 3 Topline: A Seamless Phase II/III, Observer-blind, Multi-centre, Randomized Clinical Trial to Evaluate Immunog
Patent ExpiryPatent/Exclusivity Expiry: RYTELO
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.